PASI 50 · psoriasis
FAE may leads to higher PASI 50 compared with placebo (low certainty).
1 finding from 1 review
Percentage of participants reaching PASI 75 · psoriasis
1 finding from 1 review
PASI 90 ‐ not measured · psoriasis
1 finding from 1 review
PASI score (scale range from 0 to 72 (higher score indicates more severe psoriasis)) · psoriasis
1 finding from 1 review
Withdrawals due to adverse events · psoriasis
It is very uncertain whether FAE changes AEs leading to treatment discontinuation compared with MTX (very low certainty).
1 finding from 1 review
Percentage of participants reaching PASI 75 · People with palmoplantar psoriasis
1 finding from 1 review
Withdrawals due to adverse events · People with palmoplantar psoriasis
1 finding from 1 review
Clearance rate · People with palmoplantar psoriasis
NB‐UVB showed no clear difference in clearance rate compared with topical PUVA (low certainty).
1 finding from 1 review
Participant‐rated global improvement · People with chronic plaque or guttate psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · People with chronic plaque or guttate psoriasis
NB‐UVB plus retinoid showed no clear difference in percentage of participants reaching PASI 75 compared with PUVA plus retinoid (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · People with chronic plaque or guttate psoriasis
1 finding from 1 review
Clearance rate · People with chronic plaque or guttate psoriasis
NB‐UVB plus retinoid showed no clear difference in clearance rate compared with PUVA plus retinoid (low certainty).
1 finding from 1 review
Participant‐rated global improvement · people with chronic plaque psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · people with chronic plaque psoriasis
1 finding from 1 review
Withdrawals due to adverse events · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in withdrawal due to side‐effects compared with selective BB‐UVB (low certainty).
1 finding from 1 review
Clearance rate · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in clearance rate compared with selective BB‐UVB (low certainty).
1 finding from 1 review
Participant‐rated global improvement · people with chronic plaque psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · people with chronic plaque psoriasis
1 finding from 1 review
Withdrawals due to adverse events · people with chronic plaque psoriasis
1 finding from 1 review
Clearance rate · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in clearance rate compared with bath PUVA (low certainty).
1 finding from 1 review